Home » Newsletters » BioWorld

BioWorld

Nov. 20, 2000

View Archived Issues

Correction

Other News To Note

Xoma Loses Allergan BPI Deal, Files For $112M Shelf Offering

Human Genome Project Opens Doors To Discovery, Therapies

Array Completes $49M IPO For Discovery, Other Services

Aurora Acquiring PanVera In Stock Deal Valued At $86M

Avigen, Bayer Form $60 Alliance For Hemophilia B Gene Therapy

NIH Immunologists Demonstrate Protective Salivary Stratagem Of Sand Fly Vectors In

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 17, 2024.
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.